GSEA reveals an overlap between the high level of FAM171A1, upregulated stem cell gene signatures as well as activated gene signatures for TGFβ/Smad and Wnt/β-catenin pathways, suggesting a possible involvement of FAM171A1 in the modulation of cancer stem cells. The gene discussed is TGFB1; the disease is cancer.